KIM-1, as a marker of early or active damage, may have higher expression at specific times, and its association with lifelong exposure may not be as direct or strong as its association with long-term outcomes, such as end-stage renal disease. This evidence concerns the gene HAVCR1 and stage 5 chronic kidney disease.